George Eric Davis - 15 Mar 2023 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Legal Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
15 Mar 2023
Net transactions value
-$2,129,597
Form type
4
Filing time
17 Mar 2023, 21:31:58 UTC
Previous filing
02 Mar 2023
Next filing
18 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $0 +8,900 +9.4% $0.000000 103,349 15 Mar 2023 Direct F1
transaction BMRN Common Stock Tax liability $265,414 -3,025 -2.9% $87.74 100,324 15 Mar 2023 Direct
transaction BMRN Common Stock Tax liability $1,864,183 -19,957 -20% $93.41 80,367 16 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to buy Common Stock) Award $0 +20,320 $0.000000 20,320 15 Mar 2023 Common Stock 20,320 $87.74 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units granted on March 15, 2023. Price not applicable.
F2 Option grant vests 12/48th on March 15, 2024 and 1/48th on the 15th day of each month thereafter.